Plus, Rio Tinto pushes into lithium production with $6.7bn deal and OpenAI considers a poison pill
Hedge fund had enlisted help from ex-chair Ian Read and former finance chief Frank D’Amelio
Firm is also weighing IPO while world’s largest money manager seeks to boost its presence in alternative investments
US plane maker’s withdrawal of pay offer threatens to compound industry problems
It is better to target the tech giant’s ability to entrench its power
ChatGPT maker considers largely untested company model to protect chief executive Sam Altman from outside interference
Justice department could seek ‘structural remedies’ such as forced product sales after judge’s ruling of illegal monopoly in search
Extreme volatility in price of key battery material reflects uncertainty over current global market for electric vehicles
The DoJ’s recommendations show how far the government is willing to go to shift the balance of power
Japan’s designation of Seven & i as a ‘core business’ means a deal will not be easy, but investors should benefit regardless
Canadian company’s non-binding offer to owner of 7-Eleven chain is 20% higher than initial rejected approach
Plane maker says union demands threaten company’s competitiveness
Plus, Ares scales up its real estate business
Fewer US students are taking up accountancy, and 75% of CPAs are near retirement
A world where the tech giant gets dismantled is more plausible than it was, but investors have reason to be unfazed
CBO analysis says savings from other health benefits would not offset expense of weight-loss jabs
Fund run by Jeff Smith builds $1bn stake in vaccine maker and pitches shake-up plan
Bill Ford says his approach would not change if carried interest loophole is closed
Deal would bolster Japanese group’s drive to secure supplies for home country, which relies on fossil fuel imports for energy
GLP Capital deal will add $44bn in assets to private investment group’s business
The drugmaker is worth less now than before the pandemic
Plus, Jane Street comes for Goldman’s trading crown and Byju’s can’t find the money
Loan growth has been sluggish as higher interest rates have deterred borrowers
Injunction is a blow to search giant defending three antitrust cases that threaten its core business
Ian Read has called his successors about the activist’s ideas for turning round the vaccine maker